Drug may help ease Ramazan headaches: study
Page 1 of 1 • Share
Drug may help ease Ramazan headaches: study
[You must be registered and logged in to see this image.]
NEW YORK: A painkilling, anti-inflammatory drug may help prevent headaches in Muslims fasting from dawn to dusk for Ramazan, according to a study from Israel -- where a "Yom Kippur headache" is also known.
About four in every ten people who abstain from food and water all day during the month-long Ramazan period get headaches, said the study, published in the journal Headache.
Doctors aren't quite sure what causes them. It could be dehydration, or caffeine withdrawal in people who are used to getting their morning coffee, Drescher told Reuters Health.
Drescher and his Israel-based colleagues had already shown that Jews who took the drug known as etoricoxib, or Arcoxia, before fasting for 25 hours on the Yom Kippur holiday got fewer headaches than those who didn't.
Arcoxia, a cousin of the painkiller Vioxx, isn't approved for use in the United States because the Food and Drug Administration decided it was too similar to Vioxx, which Merck pulled from the market in 2004 when it was linked to a higher risk of heart attack. But Arcoxia is available in Israel, among other countries.
The drug has a longer-lasting effect than some other painkillers, which is important because taking a pill in the middle of the day when a headache sets in would be considered breaking the fast.
"If you take Tylenol (acetaminophen)... by the time you get around to feeling the effects of the fast, the medicine is long out of your system," Drescher said.
To see how Arcoxia would work during Ramadan, the researchers assigned 222 adults planning to fast in 2010 to either take the drug or an inactive placebo pill just before the start of fasting each day. All participants recorded how often they had a headache, and how severe it was.
After a week they switched treatments.
During the first day of fasting, when headaches are thought to be most common, 21 percent of people taking Arcoxia reported having a headache, compared to 46 percent of those who took the placebo pill.
The Arcoxia group also reported fewer total headaches during that first week, the researchers wrote. And when they did have headaches, they rated them as less severe than participants taking the placebo. (Reuters)
NEW YORK: A painkilling, anti-inflammatory drug may help prevent headaches in Muslims fasting from dawn to dusk for Ramazan, according to a study from Israel -- where a "Yom Kippur headache" is also known.
About four in every ten people who abstain from food and water all day during the month-long Ramazan period get headaches, said the study, published in the journal Headache.
Doctors aren't quite sure what causes them. It could be dehydration, or caffeine withdrawal in people who are used to getting their morning coffee, Drescher told Reuters Health.
Drescher and his Israel-based colleagues had already shown that Jews who took the drug known as etoricoxib, or Arcoxia, before fasting for 25 hours on the Yom Kippur holiday got fewer headaches than those who didn't.
Arcoxia, a cousin of the painkiller Vioxx, isn't approved for use in the United States because the Food and Drug Administration decided it was too similar to Vioxx, which Merck pulled from the market in 2004 when it was linked to a higher risk of heart attack. But Arcoxia is available in Israel, among other countries.
The drug has a longer-lasting effect than some other painkillers, which is important because taking a pill in the middle of the day when a headache sets in would be considered breaking the fast.
"If you take Tylenol (acetaminophen)... by the time you get around to feeling the effects of the fast, the medicine is long out of your system," Drescher said.
To see how Arcoxia would work during Ramadan, the researchers assigned 222 adults planning to fast in 2010 to either take the drug or an inactive placebo pill just before the start of fasting each day. All participants recorded how often they had a headache, and how severe it was.
After a week they switched treatments.
During the first day of fasting, when headaches are thought to be most common, 21 percent of people taking Arcoxia reported having a headache, compared to 46 percent of those who took the placebo pill.
The Arcoxia group also reported fewer total headaches during that first week, the researchers wrote. And when they did have headaches, they rated them as less severe than participants taking the placebo. (Reuters)
Rao Muhammad Aftab- Monstars
-
Posts : 1091
Join date : 2011-02-11
Age : 35
Similar topics
» Happy Ramazan to u all.
» Lifestyle factors linked to teens' headaches
» Forex reserves ease to $17.97bn
» Forex reserves ease to $17.97bn
» Adding talk therapy to meds may ease adult ADHD
» Lifestyle factors linked to teens' headaches
» Forex reserves ease to $17.97bn
» Forex reserves ease to $17.97bn
» Adding talk therapy to meds may ease adult ADHD
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat May 04, 2024 11:49 am by ali001
» house disrepair claims
Thu May 02, 2024 4:29 pm by Ibad Khan Buledi
» Bounce n Bang: Physics puzzler
Thu May 02, 2024 11:39 am by ali001
» AIChatSY - AIChatbot Assistant
Wed May 01, 2024 10:48 am by ali001
» Storybook Magic App
Tue Apr 30, 2024 7:06 pm by ali001
» Flower Book Match3 Puzzle Game
Tue Apr 30, 2024 12:17 pm by ali001
» Avian Influenza Symptom in Chickens "Bird Flu H5N1 Virus" Vet learning materials, Poultry Farming
Sat Apr 27, 2024 9:57 am by Ibad Khan Buledi
» Aloha Planner - Note-Taker
Thu Apr 11, 2024 4:52 pm by ali001
» Streaming Guide Film TV Series
Tue Apr 09, 2024 9:39 pm by ali001